We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$88.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$74.7M
3
CONE
CyrusOne Inc Common Stock
CONE
+$31.7M
4
ABT icon
Abbott
ABT
+$25.5M
5
EXC icon
Exelon
EXC
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TISI icon
2926
Team
TISI
$77.7M
$81K ﹤0.01%
3,655
-335
-8% -$3.48K
UAVS icon
2927
AgEagle Aerial Systems
UAVS
$53.9M
$80K ﹤0.01%
67
-3
-4% -$3.54K
WVE icon
2928
Wave Life Sciences
WVE
$1.2B
$80K ﹤0.01%
40,249
+2,566
+7% +$6.29K
ABOS icon
2929
Acumen Pharmaceuticals
ABOS
$176M
$79K ﹤0.01%
+20,273
New +$110K
NL icon
2930
NLI Holdings
NL
$317M
$79K ﹤0.01%
10,981
-1,370
-11% -$9.21K
TRVN
2931
DELISTED
Trevena, Inc.
TRVN
$79K ﹤0.01%
231
-15
-6% -$4.73K
SMED
2932
DELISTED
Sharps Compliance Corp
SMED
$79K ﹤0.01%
+13,335
New +$83.8K
NGNE icon
2933
Neurogene
NGNE
$712M
$78K ﹤0.01%
2,073
-164
-7% -$9.57K
SRT
2934
DELISTED
Startek Inc.
SRT
$78K ﹤0.01%
17,716
-538
-3% -$2.54K
AMPE
2935
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$77K ﹤0.01%
548
+62
+13% +$9.05K
SYRS
2936
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$76K ﹤0.01%
6,387
-279
-4% -$4.99K
GOCO
2937
DELISTED
GoHealth
GOCO
$74K ﹤0.01%
4,164
-224
-5% -$6.97K
BCAB icon
2938
BioAtla
BCAB
$5.74M
$73K ﹤0.01%
291
+47
+19% +$19.7K
DNTH icon
2939
Dianthus Therapeutics
DNTH
$6.09B
$73K ﹤0.01%
1,564
+28
+2% +$1.53K
RVP icon
2940
Retractable Technologies
RVP
$20.1M
$73K ﹤0.01%
15,372
+2,230
+17% +$11.6K
ONCT
2941
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$73K ﹤0.01%
2,616
-134
-5% -$4.88K
MBIO icon
2942
Mustang Bio
MBIO
$4.55M
$72K ﹤0.01%
95
-12
-11% -$9.86K
RPID icon
2943
Rapid Micro Biosystems
RPID
$86.2M
$72K ﹤0.01%
+10,611
New +$78.1K
NBEV
2944
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$72K ﹤0.01%
124,186
-2,353
-2% -$1.68K
AWH
2945
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$70K ﹤0.01%
4,473
-6
-0.1% -$104
PPTA
2946
Perpetua Resources
PPTA
$3.09B
$69K ﹤0.01%
16,811
+2,456
+17% +$9.83K
PRLD icon
2947
Prelude Therapeutics
PRLD
$390M
$69K ﹤0.01%
+10,050
New +$91.9K
CLNN icon
2948
Clene
CLNN
$67.5M
$67K ﹤0.01%
846
+98
+13% +$5.93K
LITS
2949
Lite Strategy Inc
LITS
$30.9M
$66K ﹤0.01%
5,493
+510
+10% +$20K
IVC
2950
DELISTED
Invacare Corporation
IVC
$66K ﹤0.01%
46,921
-4,810
-9% -$10.3K
116 117
118
119 120

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.